Insmed Incorporated INSM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -100.32M | -13.24M | -163.56M | -328.49M | -370.02M |
| Total Depreciation and Amortization | 7.86M | 4.73M | 4.48M | 5.03M | 3.46M |
| Total Amortization of Deferred Charges | 2.69M | 2.64M | 2.59M | 2.59M | 2.56M |
| Total Other Non-Cash Items | 49.83M | -58.02M | -2.04M | 110.92M | 130.35M |
| Change in Net Operating Assets | 3.47M | -24.93M | -64.21M | -37.64M | 13.90M |
| Cash from Operations | -36.46M | -88.83M | -222.74M | -247.60M | -219.76M |
| Capital Expenditure | -5.63M | -6.26M | -3.48M | -16.59M | -2.42M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -130.02M | 30.77M | 269.00M | 406.00M | -759.82M |
| Cash from Investing | -135.65M | 24.51M | 265.52M | 389.41M | -762.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -843.00K | -827.00K | -799.00K | -776.00K | -747.00K |
| Issuance of Common Stock | 24.48M | 28.01M | 30.31M | 34.64M | 34.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23.64M | 27.18M | 29.51M | 33.86M | 33.41M |
| Foreign Exchange rate Adjustments | 269.00K | -287.00K | -553.00K | 7.00K | -976.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -148.20M | -37.42M | 71.74M | 175.68M | -949.56M |